Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

7.30USD
4:00pm EDT
Change (% chg)

$0.23 (+3.25%)
Prev Close
$7.07
Open
$7.13
Day's High
$7.48
Day's Low
$6.96
Volume
464,071
Avg. Vol
296,467
52-wk High
$9.27
52-wk Low
$4.03

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc.is engaged in developing medicines for oncology. The Company completed Phase II clinical trials of two product candidates for prostate cancer, and resumed a pivotal Phase II trial of an ultra-orphan radiotherapy candidate for pheochromocytoma. Its principal clinical-stage product candidates in... (more)

Overall

Beta: 1.78
Market Cap(Mil.): $492.39
Shares Outstanding(Mil.): 69.64
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): 110.35 35.49 39.20
EPS (TTM): 0.06 -- --
ROI: 2.46 16.99 16.19
ROE: 3.11 17.90 17.33
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks